New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...

In this interview, Dr Tiffany Braley discusses the results of her latest study and best practices for personalized patient ...

You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

The ratio of two types of bacteria in the gut microbiome may be able to predict disease severity in multiple sclerosis, ...

M.S. is a disease of the brain and spinal cord that affects almost a million people in the United States. About 1,200 here in ...

A SPECIFIC microbial ratio in the gut microbiome, characterised by a lower Bifidobacterium to Akkermansia ratio, has been ...

Scientists from Sweden’s Karolinska Institutet have uncovered new clues about how the Epstein-Barr virus (EBV) might ...

A new analysis provides substantial evidence that paramagnetic rim lesions drive disability in MS and are targetable with a ...

Myrobalan to receive over $850,000 in funding to advance the development of its GPR17 antagonist for progressive MS from the ...

It also gave University of Michigan researchers a first look at how primary progressive multiple sclerosis, the fastest-progressing version of the disease, attacks the central nervous system early on.

March is Multiple Sclerosis Awareness Month in Wisconsin. MS is a disease that impacts the brain, spinal cord and optic ...

The Epstein-Barr virus (EBV) is one of the most common human viruses worldwide. According to the Centers for Disease Control and Prevention (CDC), EBV can | Immunology ...